I think a lot of your posts add value to the SPL discussion and...

First 65 Last

Share
Profile

Follow
timferris

650 Posts.

52

09/04/24

08:57

Post #: 73251101
Share

Originally posted by col69: ↑

So Merck (our supposed partner) has now invested billions in not one, but 2 other companies for ADCs after spending years looking at Starpharma’s ADCs ….. looking like they just aren’t interested in our ADCs but hey everyone is now cheering about the fact that we are going back to the drawing board with Medicxi ?

If the Starpharma science is as good as many continuously claim on here, why is our partner Merck always buying / investing elsewhere ? Why won’t they do a deal with Starpharma after their years of research ?

https://endpts.com/merck-buys-abceutics-to-make-adcs-safer/

Merck signs small acquisition to make ADCs safer

https://www.fiercebiotech.com/biote...-3-daiichi-adcs-huge-bet-post-keytruda-future

Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future

Expand

I think a lot of your posts add value to the SPL discussion and although consistently negative, they balance those from others who are overly positive. Your arguments on this thread seem off.

Your above post can be summarised as "Merck aren't interested in our products, it's bad news that we have found someone who is". If you believe Merck have found alternative solutions (to all their ADC problems) then is it not good news that we are starting again with someone who hasn't? Or are you arguing we would be better to sit and do nothing but bemoan as the Merck ship sails off into the sunset.

SPL Price at posting: 14.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply